| Organism name | Panax quinquefolium L. |
|---|---|
| Genus | Panax |
| Family | Araliaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Panax |
|---|---|
| Linked NCBI taxonomy ID | 4053 |
| Linked level | genus |
| Family in NCBI taxonomy | Araliaceae |
|---|---|
| ID | 4050 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00003518
|
Ginsenoside Re
|
CHEMBL510095
|
C049864
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
|
|
C00031118
|
Quinquenoside III
|
No. 11 | No. 51 |
|
||||
|
C00030841
|
Notoginsenoside E
/ (+)-Notoginsenoside E |
No. 11 | No. 51 |
|
||||
|
C00030396
|
Gypenoside IV
/ Ginsenoside Rb3 |
CHEMBL449303
CHEMBL507688 CHEMBL452438 |
C044463
|
2 / 0 / 0 | No. 11 | No. 51 |
|
|
|
C00030391
|
Ginsenoside I
|
No. 11 | No. 51 |
|
||||
|
C00030268
|
Floralquinquenoside E
|
No. 11 | No. 51 |
|
||||
|
C00030390
|
Ginsenoside F3
|
CHEMBL1095004
|
2 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00030267
|
Floralquinquenoside D
|
No. 32 | No. 51 |
|
||||
|
C00030265
|
Floralquinquenoside B
|
No. 32 | No. 51 |
|
||||
|
C00030266
|
Floralquinquenoside C
/ (-)-Floralquinquenoside C |
No. 32 | No. 51 |
|
||||
|
C00031119
|
Quinquenoside L9
|
No. 32 | No. 51 |
|
||||
|
C00030392
|
Ginsenoside Ia
|
No. 32 | No. 51 |
|
||||
|
C00003520
|
Ginsenoside Rg1
|
CHEMBL501637
CHEMBL1977916 |
C035054
|
5 / 6 | No. 32 | No. 51 |
|
|
|
C00030399
|
Panaxoside Rg2
/ Ginsenoside Rg2 |
CHEMBL505747
CHEMBL1095005 CHEMBL1095006 CHEMBL1475728 |
C026474
|
5 / 0 / 0 | 7 / 2 | No. 32 | No. 51 |
|
|
C00024137
|
Pseudo-ginsenoside F11
|
CHEMBL509047
CHEMBL1899126 CHEMBL1899642 |
3 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00029447
|
24(S)-Pseudoginsenoside F11
/ 24(S)-Pseudo-ginsenoside F11 |
CHEMBL509047
CHEMBL1899126 CHEMBL1899642 |
3 / 0 / 0 | No. 32 | No. 51 |
|
||
|
C00031100
|
Pseudoginsenoside RT5
|
CHEMBL447942
|
C487714
|
No. 99 |
|
|||
|
C00030264
|
Floralquinquenoside A
/ (+)-Floralquinquenoside A |
No. 99 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003518 C00030390 C00030396 C00030399 | 0 / 0 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00003518 C00030390 C00030396 C00030399 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00024137 C00029447 C00030399 | 0 / 0 |
| P14735 | Insulin-degrading enzyme | Enzyme | C00024137 C00029447 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00024137 C00029447 | 0 / 0 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00030399 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00030399 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 200186 | CRTC2, TORC-2, TORC2 | CREB regulated transcription coactivator 2 |
C00030399
|
| 92579 | G6PC3, SCN4, UGRP | glucose 6 phosphatase, catalytic, 3 (EC:3.1.3.9) |
C00030399
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00030399
|
| 8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00030399
|
| 5105 | PCK1, PEPCK-C, PEPCK1, PEPCKC | phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32) |
C00030399
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00030399
|
| 6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00030399
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00003520
|
| 1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003520
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003520
|
| 3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003520
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00003520
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D006948 | Hyperkinesis |
C00030399
C00003520 C00003518 |
| D003928 | Diabetic Nephropathies |
C00003520
|
| D003704 | Dementia |
C00003520
|
| D019970 | Cocaine-Related Disorders |
C00030399
|
| D007249 | Inflammation |
C00003520
|
| D007859 | Learning Disorders |
C00003520
|
| D008569 | Memory Disorders |
C00003520
|